Cardiac Surgery Clinical Trials
The Division of Cardiac Surgery is internationally respected by other heart experts for participating in, and leading, clinical trials that advance surgical treatment of heart disease and provide options for patients for whom traditional surgical solutions are not an option.
Two Clinical Trials for HLHS Patients
Dr. Sunjay Kaushal, M.D., Ph.D., is leading research to address hypoplastic left heart syndrome (HLHS), a life-threatening congenital heart condition in newborn babies. If left untreated, HLHS is usually fatal in the first weeks of life. Currently there is no cure for this devastating condition; but, by way of two new clinical trials, Dr. Kaushal, the University of Maryland Children’s Hospital, and its team are preparing to take a major step to improve – and possibly save – the lives of our tiniest patients. Click here to learn more.
Cardiothoracic Surgical Trials Network
The Division was selected to join the Cardiothoracic Surgical Trials Network, a National Heart, Lung, and Blood Institute-supported consortium of cardiac surgery centers, to evaluate new surgical techniques, technologies, devices and innovative pharmaceutical and bioengineered products directed at improving adult cardiovascular outcomes.
Types of clinical trials at the University of Maryland include:
- New minimally invasive techniques for patients deemed too high-risk for traditional surgery
- Investigation of new ventricular assist devices
- New approaches for valve procedures, including transapical and catheter-based surgeries
Read about the COAPT clinical trial for patients with mitral valve regurgitation.
For more information or to make an appointment, please call 1-800-492-5538.